Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of Schizophrenia

Sponsor
Shanghai Mental Health Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05310955
Collaborator
Shanghai University of Traditional Chinese Medicine (Other)
60
1
2
10
6

Study Details

Study Description

Brief Summary

The purpose of this study is to observe the intervention effect of shen-based Qigong exercise on residual symptoms of schizophrenia.

Condition or Disease Intervention/Treatment Phase
  • Other: daily rehabilitation interventions
  • Other: shen-based Qigong exercise
N/A

Detailed Description

Shen-based Qigong exercise is a new kind of health-care Qigong exercise based on the theory of traditional Chinese medicine, aiming at the characteristics of schizophrenia. In this study, a randomized controlled trial was conducted to observe the rehabilitation effect of this new exercise on residual symptoms of schizophrenic patients. Questionnaire, test and other experimental materials were used to evaluate the intervention effect of 12-week shen-based Qigong exercise on psychiatric symptoms, cognitive function, quality of life and social function of schizophrenic patients. At the same time, the related physical function and cardiac function indexes were used to evaluate the physical and cardiac rehabilitation effects of the exercise on patients from the aspects of "body" and "heart", so as to verify whether Qigong exercise has the effects of adjusting body and heart.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Discussion on the Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of Schizophrenia Based on the Theory of "Heart Dominating Mind" and "Body-spirit Syncretism" in Traditional Chinese Medicine
Anticipated Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Control group

daily rehabilitation interventions

Other: daily rehabilitation interventions
including Naikan therapy, Morita therapy, group art therapy, group painting therapy

Experimental: Interventional group

daily rehabilitation interventions and shen-based Qigong exercise

Other: daily rehabilitation interventions
including Naikan therapy, Morita therapy, group art therapy, group painting therapy

Other: shen-based Qigong exercise
a 12-week intervention of shen-based Qigong exercise : exercise 5 days a week, about 30 minutes a day

Outcome Measures

Primary Outcome Measures

  1. change of the Scale for the Assessment of Negative Symptoms (SANS) [Change from Baseline at 3 months]

    Negative symptoms will be evaluated using the Scale for the Assessment of Negative Symptoms (SANS). The scale made up for the lack of attention to negative symptoms in previous psychiatric rating scales. It contains five subscales: affective blunting, alogia, avolition/apathy, anhedonia/asociality, and attention. A total of 24 items were scored at 6 levels for each item.

Secondary Outcome Measures

  1. change of Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) [Change from Baseline at 3 months]

    RBANS will be used to assess global cognitive function. RBANS yields scaled scores for 5 cognitive domains and shows a good effect in cognitive assessment of patients with schizophrenia.

  2. change of event-related potential P300 (ERP P300) [Change from Baseline at 3 months]

    ERP P300 will be used to assess global cognitive function. ERP P300 is an endogenous cognitive component related to high-level psychological activities such as attention, memory, feeling, learning and reasoning. It has good stability and can reflect the level of cognitive function from different aspects.

Other Outcome Measures

  1. change of n-back task [Change from Baseline at 3 months]

    Specific cognitive domain--working memory will be assessed by n-back task. N-back task paradigm is the most classical paradigm in working memory research.

  2. change of 36-item Short Form Health Survey(SF-36) [Change from Baseline at 3 months]

    36-item Short Form Health Survey(SF-36)will be used to assess the health-related quality of life of patients. SF-36 is one of the most commonly used standardized measurement tools for quality of life in the world, including eight subscales, a total of 36 items, involving physical and mental health.

  3. change of Social-Adaptive Functioning Evaluation (SAFE) [Change from Baseline at 3 months]

    Social functions will be assessed using Social-Adaptive Functioning Evaluation (SAFE). SAFE can evaluate the social adaptation function of patients with mental disorders over 18 years old. It has a total of 19 items, divided into basic life skills, advanced life skills, social skills and communication skills in four areas; each item 0-4 score, the higher the score, the more serious the damage.

  4. change of the Scale for the Assessment of Positive Symptoms (SAPS) [Change from Baseline at 3 months]

    Positive symptoms will be evaluated using the Scale for the Assessment of Positive Symptoms (SAPS). SAPS measures positive symptoms on a 34 item, 6-point scale, a total of 170 points. Items are listed under hallucinations, delusions, bizarre behavior, and positive formal thought disorder.

  5. change of heart rate variability (HRV) [Change from Baseline at 3 months]

    Heart rate variability (HRV) will be used as the evaluation index for cardiac function. HRV is a widely used non-invasive tool for evaluating cardiac autonomic nerve function.

  6. change of height [Change from Baseline at 3 months]

    Height will be measured using a height ruler, expressed in meters.

  7. change of weight [Change from Baseline at 3 months]

    Weight will be measured using a weighting scale, expressed in kilograms.

  8. change of waistline [Change from Baseline at 3 months]

    Waistline will be measured using a flexible rule, expressed in centimeters.

  9. change of blood pressure [Change from Baseline at 3 months]

    Blood pressure will be measured using a sphygmomanometer, expressed in millimeter of mercury.

  10. change of gait data [Change from Baseline at 3 months]

    Acquire gait data in a quiet, well-lit room. Specify the walking area to guide the participants to complete the walking cycle.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Han Chinese population

  2. age ≥ 18 years

  3. education level ≥ 6 years, can fill in the questionnaire independently, have enough audio-visual level to complete the necessary examination

  4. assessed by MINI 7.0 and satisfied with the diagnostic criteria for schizophrenia based on the Diagnostic and Statistical Manual of Mental Disorders, fifth edition(DSM-5)

  5. patients with schizophrenia residing in the rehabilitation ward, without relapse in the past 6 months

  6. residual negative symptoms, with at least one item ≥ 2 on the negative subscale of PANSS (N1-N7)

  7. taking second generation antipsychotics

  8. no training history of traditional Chinese exercises

  9. agreement to participate in the study and willing to give written informed consent

Exclusion Criteria:
  1. having severe physical diseases such as cardiovascular, lung, liver, kidney, and hematopoietic diseases

  2. satisfied with the diagnostic criteria for other mental disorders based on DSM-5

  3. having alcohol or substance abuse/dependence

  4. having mental retardation(WAIS<70) and/or severe cognitive impairment(MMSE<24)

  5. having visual and / or hearing problems, unable to complete the relevant test

  6. electroconvulsive or repetitive transcranial magnetic stimulation(rTMS) therapy in the past 3 months

  7. currently enrolled or participated in other clinical studies in the past 3 months

  8. participating in regular exercise training in the past 6 months

  9. failure to sign or refuse to sign informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shanghai Mental Health Center Shanghai Shanghai China 200030

Sponsors and Collaborators

  • Shanghai Mental Health Center
  • Shanghai University of Traditional Chinese Medicine

Investigators

  • Study Chair: Qing Fan, Shanghai Mental Health Center
  • Study Chair: Xiaodan Liu, School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shanghai Mental Health Center
ClinicalTrials.gov Identifier:
NCT05310955
Other Study ID Numbers:
  • YSF2021-59
First Posted:
Apr 5, 2022
Last Update Posted:
Aug 12, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 12, 2022